Johnson & Johnson Discussions to License its COVID-19 Vaccine to Aspen Reach Advanced Stage

November 30, 2021 – Johnson &Johnson is pleased to reach an advanced stage in its discussions for a potential licensing agreement for its COVID-19 vaccine with Aspen SA Operations (Pty) Ltd, which is based in South Africa. The parties will continue to work toward a definitive agreement that builds on their existing manufacturing collaboration and would enable the first COVID-19 vaccine to be manufactured and sold by an African company, in Africa and for people living in Africa. Currently, COVID-19 vaccination rates are significantly lower across Africa compared to those seen in high-income countries.“Since the earliest days of the pandemic we have been committed to supporting Africa’s response to COVID-19 through our vaccine clinical development program, large-scale implementation studies, first-of-their-kind purchase agreements and COVID-19 vaccine manufacturing at Aspen,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer. “Everyone at Johnson &Johnson is very proud of our ongoing collaboration with Aspen, which unites global and national expertise in the effort to support the vaccination of populations who are most in need at this critical stage of the pandemic.”The timing of the signing of a final agreement is dependant on a number of factors. The license under discussion would enable Aspen, using COVID-19 vaccine drug substance supplied by Johnson &Johnson, to produce Aspen-brand...
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news

Related Links:

When Jeremy Luban first looked over the genetic sequence of the Omicron variant on his phone one day last November, it was five o’clock in the morning. But even at that hour, the University of Massachusetts virus expert knew right away Omicron was a problem. First, there was the sheer number of new mutations—by some counts, as many as 50, with 30 of them in the critical places that vaccines and drug treatments target. Second, this new version of the SARS-CoV-2 virus seemed to appear out of nowhere, unpredictably and with no immediately obvious connection to previous variants. [time-brightcove not-tgx=”tru...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
The Biden Administration has officially withdrawn a rule that would have required workers at big companies to get vaccinated or face regular COVID testing requirements. The Occupational Safety and Health Administration confirmed the withdrawal Tuesday. But the agency said it still strongly encourages workers to get vaccinated. In early November, OSHA announced a vaccine-or-test mandate for companies with at least 100 employees. The rule—which would have impacted more than 80 million U.S. workers—was originally set to go into effect on Jan. 4. But numerous states and business groups challenged the rule in court....
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 News Desk wire Source Type: news
In conclusion, the oral LTB-adjuvanted multi-epitope SARS-CoV-2 vaccine triggered versatile humoral, cellular and mucosal immune responses, which are likely to provide protection, while also minimizing technical hurdles presently limiting global vaccination, whether by priming or booster programs.PMID:35078662 | DOI:10.1016/j.vaccine.2022.01.025
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research
In this study we assess the potential of a vaccine formulation based on the recombinant RBD domain of SARS-CoV-2 expressed in the thermophilic filamentous fungal strain Thermothelomyces heterothallica and the hepatitis B virus (HBV) core protein. Functional humoral and cellular immune responses were detected in mice. To our knowledge, this is the first report on the immune evaluation of a biomedical product obtained in the fungal strain T. heterothallica. These results together with the intrinsic advantages of this expression platform support its use for the development of biotechnology products for medical purpose.PMID:35...
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research
Am J Public Health. 2022 Feb;112(2):255-261. doi: 10.2105/AJPH.2021.306578.ABSTRACTMandatory vaccination has been a highly disputed policy for tackling infectious diseases. Here I argue that a universal mandatory vaccination policy for the general public against the COVID-19 pandemic is ethically preferable when grounded in the concept of solidarity, which is defined by Barbara Prainsack and Alena Buyx as an enacted commitment to a relevant respect recognized by a group of individuals with equal moral status. This approach is complementary to utilitarian accounts and could better address other reasonable oppositions to man...
Source: American Journal of Public Health - Category: International Medicine & Public Health Authors: Source Type: research
Am J Public Health. 2022 Feb;112(2):220-222. doi: 10.2105/AJPH.2021.306585.ABSTRACTThe COVID-19 pandemic has highlighted racial and ethnic disparities, most recently in vaccine administration. The EVE (Evaluating Vulnerability and Equity) Model combines a community's vulnerability with vaccination rates to enhance the equity of vaccine distribution in an intentional, targeted manner. When applied to Milwaukee County, Wisconsin, two extreme categories of vaccination status were identified to aid in resource allocation and messaging: populations with high vulnerability and low vaccination levels, and, conversely, those with ...
Source: American Journal of Public Health - Category: International Medicine & Public Health Authors: Source Type: research
Am J Public Health. 2022 Feb;112(2):255-261. doi: 10.2105/AJPH.2021.306578.ABSTRACTMandatory vaccination has been a highly disputed policy for tackling infectious diseases. Here I argue that a universal mandatory vaccination policy for the general public against the COVID-19 pandemic is ethically preferable when grounded in the concept of solidarity, which is defined by Barbara Prainsack and Alena Buyx as an enacted commitment to a relevant respect recognized by a group of individuals with equal moral status. This approach is complementary to utilitarian accounts and could better address other reasonable oppositions to man...
Source: Am J Public Health - Category: International Medicine & Public Health Authors: Source Type: research
Am J Public Health. 2022 Feb;112(2):220-222. doi: 10.2105/AJPH.2021.306585.ABSTRACTThe COVID-19 pandemic has highlighted racial and ethnic disparities, most recently in vaccine administration. The EVE (Evaluating Vulnerability and Equity) Model combines a community's vulnerability with vaccination rates to enhance the equity of vaccine distribution in an intentional, targeted manner. When applied to Milwaukee County, Wisconsin, two extreme categories of vaccination status were identified to aid in resource allocation and messaging: populations with high vulnerability and low vaccination levels, and, conversely, those with ...
Source: Am J Public Health - Category: International Medicine & Public Health Authors: Source Type: research
CMAJ Open. 2022 Jan 25;10(1):E43-E49. doi: 10.9778/cmajo.20210084. Print 2022 Jan-Mar.ABSTRACTBACKGROUND: There has been concern about declining routine vaccination rates during the COVID-19 pandemic. We evaluated the impact of the COVID-19 pandemic on early childhood vaccination rates at 2 sites of an academic family health team in the Greater Toronto Area, Ontario, serving both an urban and suburban patient population.METHODS: We conducted a pre-post analysis of vaccination records from Jan. 1, 2018, to Nov. 30, 2020, for a cohort of children born between Jan. 1, 2018, and Aug. 31, 2020, from the electronic medical recor...
Source: cmaj - Category: General Medicine Authors: Source Type: research
Cancers, Vol. 14, Pages 613: The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease Cancers doi: 10.3390/cancers14030613 Authors: Sebastian Krug Maryam Khosravian Julia Weissbach Katharina George Marko Damm Jakob Garbe Jens Walldorf Philipp A. Reuken Tania Amin Alexander Siebenhüner Jonas Rosendahl Thomas M. Gress Patrick Michl Jörg Schrader Anja Rinke The assessment of cancer patient care during the COVID-19 pandemic has been mainly reported from a physician’s perspective. Patients with rare tumor entities such as neuroendocrine tumors (NET), wh...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research
More News: African Health | COVID-19 | Health Management | Legislation | Pandemics | Pharmaceuticals | Research | South Africa Health | Study | Vaccines